Biography
Roberts received her B.S. degree in Economics from the Wharton School at The University of Pennsylvania in Philadelphia, Pennsylvania, her M.S. in Health Systems from the School of Industrial and Systems Engineering at the Georgia Institute of Technology in Atlanta, Georgia, and her Ph.D. from the College of Pharmacy at the University of New Mexico (UNM) in Albuquerque, New Mexico. In the years prior to becoming a faculty member at UNM, Dr. Roberts was a health services researcher with a number of health care organizations to include Kaiser Permanente Georgia, Lovelace Respiratory Research Institute, and Lovelace Clinic Foundation.
Personal Statement
Roberts' research has focused on outcomes research related to pharmaceutical treatments. Her main interest is in treatments for chronic conditions, and in particular treatments for chronic obstructive pulmonary disease (COPD). She has extensive experience with database studies. Current interests include pharmacoeconomics and causal inference methods.
https://www.researchgate.net/profile/Melissa_Roberts3
Areas of Specialty
Pharmacoepidemiology
Pharmacoeconomics
Comparative effectiveness
COPD
Education
PhD, University of New Mexico, 2013 (Pharmacy)
MS, Georgia Institute of Technology School of Industrial and Systems Engineering, 1999 (Health Systems)
BS, Wharton School at the University of Pennsylvania in Philadelphia
Achievements & Awards
2022 College of Pharmacy Faculty Appreciation Award - Graduate Students
Key Publications
Journal Article
Mapel, D W Roberts, Melissa Davis, J Budesonide/formoterol therapy: effective and appropriate use in asthma and chronic obstructive pulmonary disease. Journal of comparative effectiveness research 10.2217/cer-2019-0161
Journal Article
Roberts, Melissa Erdei, Esther O Comparative United States autoimmune disease rates for 2010-2016 by sex, geographic region, and race. Autoimmunity reviews 10.1016/j.autrev.2019.102423
Journal Article
Roberts, Melissa Takeda, Mikiko Y Kindilien, Shannon Barqawi, Yazan Borrego, Matthew E Assessment of components included in published societal perspective or QALY outcome economic analyses for antiepileptic drug treatment in chronic epilepsy Expert Review of Pharmacoeconomics & Outcomes Research 10.1080/14737167.2018.1489243
Journal Article
Roberts, Melissa Mapel, Douglas W Bruse, Shannon Petersen, Hans Nyunoya, Toru Development of a modified BODE index as a mortality risk measure among older adults with and without chronic obstructive pulmonary disease American journal of epidemiology doi.org/10.1093/aje/kwt087
Journal Article
Roberts, Melissa Mapel, Douglas W Hartry, Ann Von Worley, Ann Thomson, Heather Chronic pain and pain medication use in chronic obstructive pulmonary disease. A cross-sectional study Annals of the American Thoracic Society
Research and Scholarship
Roberts MH, Mapel DW, Ganvir N, Dodd MA. Frailty among older individuals with and without COPD: A cohort study of prevalence and association with adverse outcomes. Int J Chron Obstruct Pulmon Dis. 2022;17:701-717
Roberts MH, Ferguson G. Real-world evidence: bridging gaps in evidence to guide payer decisions. Pharmacoecon Open. 2021;5(1):3-11.
Roberts MH, Erdei E. Comparative United States autoimmune disease rates for 2010-2016 by sex, geographic region, and race. Autoimmun Rev. 2020;19(1):102423.
Roberts MH, Mapel DW, Hartry A, Von Worley A, Thomson H. Chronic pain and pain medication use in chronic obstructive pulmonary disease: a cross-sectional study. Ann Am Thorac Soc. 2013;10(4):290-8.
Roberts MH, Mapel DW, Bruse S, Petersen H, Nyunoya T. Development of a modified BODE index as a mortality risk measure among older adults with and without chronic obstructive pulmonary disease. Am J Epidemiol. 2013;178(7):1150-60.